A Systematic Review of Procedural Complications from Transforaminal Lumbar Puncture for Intrathecal Nusinersen Administration in Patients with Spinal Muscular Atrophy

RESULTS

A total of 317 articles were identified by searching the 3 data bases, in which there were 151 unique articles after duplicates were reviewed and removed. In addition, 137 records were excluded after reviewing the article abstracts, because they were either animal research studies (n = 9), did not include a transforaminal approach for intrathecal access (n = 125), or were not research articles (n = 1) and articles not available in English (n = 2). Fourteen full-text articles were then reviewed and 1 additional article was excluded because it did not include the number of injections performed (Figure). Most interesting, despite not including “SMA” in the search terms, no additional articles were identified outside of this patient population. Only 12 articles advocated for the transforaminal approach and 1 article (with the highest complication rate) argued against the safety of this approach, thus further demonstrating the selection bias present in these articles. The included articles are summarized below and in Table 2.

In 2018, Mousa et al⁴ published a review of 26 children, undergoing a total of 104 intrathecal injections. There were 44 injections performed in 11 patients with complex spines, all of which were preceded by a noncontrast lumbar spine CT. There were 19 injections performed via an interspinous approach, 3 via cervical puncture, and 7 patients underwent a total of 22 transforaminal injections. Three of the transforaminal injections were performed by using conebeam CT (CBCT) and 19 by using a biplane fluoroscopy machine. The spinal needles were 22-ga with the length dependent on patient body habitus, but the type of needle was not noted. They report a single adverse event of meningismus and back pain at the injection site, but it is uncertain if this was a patient undergoing a transforaminal approach. For the purposes of this analysis, this was included as a CIRSE grade 1 adverse event. In addition, they note that a transforaminal approach was preferable to a cervical puncture when available.

The same year, Nascene et al⁵ published a review of 26 transforaminal injections in 9 patients during a 21-month period. Two patients did not have SMA (both were complicated postoperative patients requiring myelography) and 1 injection was performed with CT guidance and the other under fluoroscopy. All 7 patients with SMA underwent preprocedural imaging and CT was used for procedural guidance. The review noted that 22-ga Quincke (cutting) needles were used and 24 total injections were performed. Four patients developed self-limited headaches and 1 reported injection site pain, for a total of 5 CIRSE grade 1 adverse events. These data are not included in the 2018 data because they overlap with an ensuing article from the same group published in 2020.

Finally, the last article from 2018 was published in Muscle and Nerve by Geraci et al,⁶ who had a total of 14 injections in 5 patients. This article was slightly different in that patients did not undergo preprocedural imaging and instead had a full diagnostic-quality CT of the lumbar spine at the time of intrathecal injection. CT was also used to guide needle placement and a 22-ga Chiba needle was used for each procedure. A single patient developed postprocedural headache, CIRSE grade 1.

For 2018, there were a total of 36 transforaminal injections published with 2 adverse events reported, both CIRSE grade 1 (adverse event rate 5.6%).

The following year, 2019, there were 2 published studies. Bortolani et al⁷ performed 27 transforaminal injections in 7 patients, all of whom had preprocedural imaging. All procedures were performed under CT guidance, by using a 22-ga spinal needle in 4 patients and a 20-ga Chiba needle in 3 patients. They reported that 1 patient developed a mild headache, CIRSE grade 1. Towbin et al⁸ had a cohort of 9 patients who underwent 42 transforaminal injections. Patients underwent either radiography or CT before the procedure and the procedure was performed under fluoroscopic or CBCT guidance. They used 22-ga Quincke needles for most of the procedures; however, Whitacre needles were used if the patient had a history of prior spinal headache, and a coaxial approach was used with an 18-ga Chiba as a guide if necessitated by body habitus, while still using a 22-ga needle for dural puncture. No complications were reported.

For 2019, there were a total of 69 transforaminal injections published with 1 adverse event reported, CIRSE grade 1 (adverse event rate 1.4%). Combining the articles from the 2 years gives a total of 105 injections with 3 adverse events, again all CIRSE grade 1 (adverse event rate 2.9%).

Most the articles were published in the first half of 2020. Velayudhan et al⁹ published a series of 17 transforaminal injections in 3 patients, all of whom underwent a preprocedural planning CT and they used CT guidance for the procedure. Either a 20-ga or 22-ga Quincke needle was used for the procedure. There were 2 headaches in patients in whom 20-ga needles were used, both of which were self-limited, CIRSE grade 1. In addition, they report 3 episodes of transient radiculopathy in 2 patients, also categorized as CIRSE grade 1.

An additional single report of 1 patient undergoing a single injection was published by Cartwright et al.¹⁰ This patient was transitioned from a fluoroscopically-guided interlaminar lumbar puncture to a CT-guided transforaminal approach secondary to discomfort during prior 7 interlaminar approach procedures. No complication was reported.

Weaver et al¹¹ published the largest series of transforaminal injections – 200 injections in 28 patients. Preprocedural planning was performed with CT and a 22-ga Quincke needle was used in 199 procedures; a single procedure was performed with a 24-ga Sprotte Spinal needle (Teleflex Medical). There were 187 procedures performed with CBCT and 13 performed under fluoroscopic guidance. Three patients developed transient radiculopathy, 2 patients developed self-limited headache, and 2 patients developed headache that responded to gabapentin for a total of 7 CIRSE grade 1 complications. One patient developed meningitis that was attributed to the nusinersen after CSF tests were negative for bacterial infection (CIRSE grade 2) and 1 patient was admitted for observation and antibiotics after possible traversal of the large bowel during the procedure (CIRSE grade 3).

Another large group of procedures, 85 transforaminal injections in 9 patients, was reported the same year by Shokuhfar et al,¹² including both adult and pediatric patients. All patients underwent preprocedural planning CT and most patients underwent a fluoroscopically-guided procedure (all pediatric patients and 29 of 39 adult patients), with the remainder of procedures performed using CBCT guidance. Whitacre needles were used for all procedures; however, the gauge was not reported. Two complications were reported, but the technique used was not included. A pediatric patient developed constipation and urinary tenesmus, which was successfully treated with polyethylene glycol 3350 (Miralax) (CIRSE grade 1). An adult patient developed bilateral radicular pain after the first injection; no epidural hematoma was visualized on imaging and the pain responded to a single dose of opioid medication (CIRSE grade 1).

A different approach was described by Jacobson et al,¹³ using a coaxial curved-needle technique in 59 procedures performed in 12 patients. Three of the patients had preprocedural CT with the procedures performed under fluoroscopy using a 25-ga coaxial Pakter Curved Needle (Cook). One patient developed a headache that required admission for transforaminal epidural blood patch placement (CIRSE grade 3) and 2 patients had dorsal muscular arterial branch puncture during placement of the 21-ga coaxial needle without complication (CIRSE grade 1).

Özütemiz et al¹⁴ published a series of 65 transforaminal injections in 13 patients; however, there is a 10-month overlap with the previous publication from this group (Nascene et al,⁵ 2018). It is unclear how many of these patients were included in the original analysis. For the purposes of our analysis, we elected to include this cohort of patients in the analysis. All patients underwent preprocedural low-dose CT scanning of the lumbar spine. One patient started the procedure by using fluoroscopic guidance but was transitioned to CT guidance after concern for renal puncture (without adverse outcome – CIRSE grade 1); the remaining procedures were performed under CT guidance from the initiation. The length of the needle was determined by patient body habitus with 64 patients having the procedure performed with a 22-ga Quincke needle and 1 patient with a 25-ga Quincke needle. Eight patients had postprocedural headaches, 1 of which lasted more than a day (CIRSE grade 1). One patient developed hot flashes, 2 had soreness, and 1 developed self-limited radicular pain (CIRSE grade 1). There was a single CIRSE grade 2 complication of radiculopathy requiring emergency department admittance and use of narcotic pain management.

Spiliopoulos et al¹⁵ reported on 20 transforaminal injections performed in 5 patients. All patients underwent lumbar spine CT for procedure planning with limited CT used to evaluate the needle trajectory and advancement. Procedures were performed by using 23-ga Chiba needles. No complications were reported.

Finally, an article was published by Cordts et al¹⁶ detailing their experience performing 4 transforaminal injections in 3 patients. None of the patients underwent preprocedural imaging but CT was used for procedural guidance. Needle type and length were not reported, but the needle gauge was 18–22. Two patients developed self-limited radiculopathy (CIRSE grade 1). One patient developed severe head and back pain for 1 week, necessitating hospitalization; however, the treatment was not reported (CIRSE grade 3). Given the 75% adverse event rate in their patient population, the authors advocate for consideration of laminar drilling to create a posterior approach. However, the needle gauge used in this study was significantly larger than that in any of the other publications, which may have contributed to the higher complication rate.

For 2020, there were 451 transforaminal injections published with a total of 36 adverse events (6.9% adverse event rate). Of the adverse events, 30 were CIRSE grade 1, 2 were grade 2, and 3 were grade 3. In total, this gives an aggregate of 582 injections with an overall adverse event rate of 5.8% (34 total adverse events) as detailed in Table 2. The most common type of complication was headache (n = 19), followed by radiculopathy (n = 10) and back pain/soreness (n = 4). Most of the adverse events were CIRSE grade 1 (34 – 5.8% rate) with 0.3% grade 2 and 0.5% grade 3.

When available, type of needle used in the procedure was evaluated; note that this information was not included in all studies. The number of procedures performed with cutting (Quincke) needles was 216 with 17 CIRSE grade 1 adverse events. Noncutting needle types included Whitacre, Chiba, spinal, and the Pakter Curved Needle with a total of 206 procedures performed with 7 adverse events (6 CIRSE grade 1, 1 CIRSE grade 3). The Pakter Curved Needle system was the only curved system used and had 3 adverse events of which 2 were grade 1 and 1 was grade 3 (5.1% adverse event rate). The overall adverse event rate for cutting needles was 7.9% and for noncutting needles was 3.4% (Table 3).

Procedural guidance varied on the basis of operator preference; granular delineation was not included in all studies. Cross-sectional guidance techniques provide the advantage of direct visualization of other structures that may be encountered along the needle path, with a theoretic decreased risk of traversing the bowel or kidneys with these far lateral needle approaches. Most procedures were performed under CT guidance, but several authors noted transitioning patients to CT or CBCT after unsuccessful fluoroscopic procedures (Table 4). The higher adverse event rate may therefore reflect the more complicated anatomy necessitating CT guidance. The only 2 groups included in the fluoroscopically-guided procedures were the patients reported by Jacobson et al¹³ using the curved needle technique and the pediatric cohort reported by Shokuhfar et al.¹² Towbin et al⁸ did not report the number of each technique used, but did note that CBCT and CT were initially used for guidance before transitioning to fluoroscopy. Nearly all of the studies included preprocedural CT for planning purposes with the following exceptions: Jacobson et al¹³ (curved coaxial technique), Cordts et al¹⁶ (larger needle bore), and Geraci et al⁶ (instead performed full-dose CT for each procedure). Given the additional variables in each of these publications, the decision was made not to separately evaluate for any correlation between performing preprocedural imaging and the adverse event rate.

At our institution, a total of 42 transforaminal injections have been performed in 8 patients. All procedures were performed with 22-ga Quincke type spinal needles with lengths of 3.5, 5, or 7 inches depending on preprocedural images obtained for planning. A single adverse event occurred (2.4% adverse event rate) in 2018, which was deemed to be a CIRSE grade 2 because the patient required inpatient hospitalization for pain management after developing a noncompressive epidural hematoma. The epidural hematoma spontaneously resolved without surgical intervention.